Bepirovirsen Liver Biopsy Study

Phase 3 Trials Show Bepirovirsen Achieves Functional Cure for Hepatitis B in 20% of Patients

Bepirovirsen reduced posttreatment markers of hepatitis B infection at 72 weeks, with 20% of recipients achieving functional cure vs none gi

<![CDATA[Functional Cure of Hepatitis B Infections Among Patients Coinfected With HIV]]>

Rewe-Rückruf: Gefährliche Hepatitis-A-Viren in TK-Beeren nachgewiesen

Vorsicht beim Frühstück: Eine Beerenmischung ist mit gefährlichen Viren belastet. Das Bundesamt warnt vor dem Verzehr. Mehrere Bundesländer

Population-based prevalence and screening gaps of hepatitis C, B and D, Germany, 2020 to 2021

BACKGROUND Chronic hepatitis C (HCV) and hepatitis B (HBV) viruses remain major causes of liver-related morbidity and mortality. Despite a l

Lenacapavir and the shift to NRTI-free, long-acting HIV treatment: implications for HBV patients

An exciting shift is underway in progress towards tackling HIV as a global public health threat, as we enter a new era of nucleotide and nuc